
Medications
GLP-1s for diabetes and weight loss
Monthly Cost
$99-$299
Speed to Start
Moderate
Trustpilot
Not yet rated
Est. 2021
About 9amHealth
9amHealth was founded in 2021 with a focused mission: making cardiometabolic care β the intersection of heart health, diabetes, and weight management β accessible, affordable, and clinically excellent through telehealth. Unlike platforms that treat weight loss as an isolated goal, 9amHealth approaches GLP-1 prescribing within the broader context of metabolic syndrome, addressing blood sugar, cholesterol, blood pressure, and weight as interconnected conditions. This clinical philosophy produces a more thorough treatment experience than most standalone weight loss services.
The platform prescribes both compounded and brand-name GLP-1 medications for diabetes and weight loss, with monthly costs ranging from $99-$299Β depending on the medication and plan selected. Critically, 9amHealth accepts insurance, which can significantly reduce out-of-pocket costs for patients with qualifying coverage. The company has also partnered with Lilly Direct, Eli Lilly’s direct-to-patient pharmacy channel, giving patients streamlined access to brand-name tirzepatide (Zepbound/Mounjaro) at competitive pricing. This partnership signals pharmaceutical-level trust in 9amHealth’s clinical operations.
Clinical outcomes data from 9amHealth is compelling: the platform reports an average weight reduction of 17.6% among patients in its weight management program, a figure that rivals the results seen in clinical trials of brand-name semaglutide and tirzepatide. Every patient receives comprehensive lab testing, ongoing metabolic monitoring, and access to a registered dietitian for nutritional counseling. The care team includes board-certified endocrinologists and internists, not just general practitioners β a level of specialist oversight that distinguishes 9amHealth from most telehealth GLP-1 providers.
9amHealth holds an A rating with the Better Business Bureau, reflecting solid business practices and complaint resolution. The platform does not yet have a Trustpilot presence, so large-scale independent consumer review data is not available. However, the combination of published outcomes data, specialist-led care, and the Lilly Direct partnership provides a strong foundation of clinical credibility. Our editorial team was particularly impressed by the cardiometabolic focus, which ensures patients receive treatment for the root causes of metabolic disease rather than just the number on the scale.
The support level at 9amHealth is high, with regular provider check-ins, dietitian consultations, lab reviews, and messaging access to the care team. The platform is designed for patients who want comprehensive metabolic health management, not just a GLP-1 prescription. Pricing is transparent and competitive, especially for patients who can leverage insurance coverage or the Lilly Direct partnership. For patients seeking a clinically serious, outcomes-driven approach to GLP-1 therapy within a broader metabolic health framework, 9amHealth is one of the strongest options we have reviewed.
At a Glance
Medications Offered
GLP-1s for diabetes and weight loss
Both
Cost & Insurance
- Monthly: $99-$299
- 6-month estimate: $594-$1,794
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: Lilly Direct partner for FDA-approved medications
- BBB Rating: A
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
What the 9amHealth Intake Looks Like
We walked through 9amHealth’s intake ourselves and came away with one of the longest and most clinically thorough flows in our catalog. 9amHealth is structurally a chronic-disease and metabolic-health program rather than a single-product GLP-1 funnel β the screening reaches into diabetes, blood pressure, cholesterol, kidney, and cardiac territory before it even gets to body metrics, and the medication review is the most detailed we have walked.
Among the strongest in our catalog. MTC and MEN syndrome named explicitly with family framing, severe diabetic gastroparesis as a specific marker most platforms omit, three-tier categorized medication review (diabetes / BP / cholesterol with brand-and-generic), critical-conditions screen covering CKD, cirrhosis, organ transplant past 12 months, active cancer, CHF, and CAD. The deduction is the absence of a mental-health, eating-disorder, or substance-use screen.
31 screens is long, account creation comes mid-flow, and the medication review alone takes five separate screens. No fake-urgency timers, no testimonial walls. Pricing is two-part: $119/month for the Healthy Weight Journey membership with the medication cost EXPLICITLY separate. The benefits dropdown is captured for downstream insurance coordination but does not gate self-pay candidates (unlike Omada).
The 15 Stages
Clinical Safety Screens Performed
Most GLP-1 platforms ask “are you on any medications?” with a yes/no toggle and a free-text field. 9amHealth runs three separate categorized screens β diabetes meds, blood-pressure meds, cholesterol/triglyceride meds β each listing six-to-seven specific drugs by both brand and generic name, plus an “additional prescriptions” Y/N follow-up and a separate over-the-counter/vitamins/supplements question. The BP screen even distinguishes Metoprolol Tartrate (Lopressor) from Metoprolol Succinate (Toprol XL) as separate options β the immediate-release versus extended-release distinction is meaningful for cardiac patients but rarely surfaced in cash-pay funnels. The depth supports the program’s positioning as a chronic-disease management offering rather than a single-product GLP-1 funnel.
9amHealth asks “Who provides your health benefits? This is usually your employer or a benefits program your employer participates in” via a dropdown, but unlike sponsor-gated platforms (Omada, Transcarent), the answer does NOT block self-pay candidates. The data is used downstream for medication coordination β the platform attempts to leverage existing employer or insurance coverage for the patient’s prescription costs while the patient pays the $119/month membership fee directly. This hybrid model preserves access for patients without sponsorship while still capturing benefits data when available.
Two structural choices reinforce 9amHealth’s medical seriousness. First, the platform surfaces a real Health Information Exchange Network consent interstitial explaining that medical-record data is shared between healthcare organizations involved in the patient’s care for “reducing clinical risk” and “limited and secure access” β this is the same data-sharing infrastructure used by hospital systems, not a marketing checkbox. Second, the flow asks “What is your preferred language to receive medical care?” via a dropdown β language preference is rarely captured in our catalog and matters operationally for clinician matching.
9amHealth charges $119/month for the Healthy Weight Journey membership at Stripe Link checkout β covering personalized care plan, on-demand 1:1 visits, metabolic lab tests, behavioral and lifestyle coaching, prescription management, insurance navigation, an optional connected weight scale, ongoing 1:1 check-ins, and unlimited specialist access. The medication cost is explicitly separate: “Please note: The cost of medication is not included in the Healthy Weight Journey program. We will work with your insurance to get your medication costs covered or provide you with alternative options.” A patient on a brand-name GLP-1 with no insurance coverage could pay $119 + the cash-pay drug cost (often $300-$1,000+/month for branded Wegovy or Zepbound). Compounded options through 9amHealth’s network would be significantly cheaper. Cancellable any time; the first month is charged immediately and auto-renewal begins month two.
No validated PHQ-2 or PHQ-9 mental-health instrument, no anxiety/depression checkbox, no suicidality. No eating-disorder screen. No alcohol or tobacco/nicotine question. No broader surgery history beyond the FDA black-box screen β gastric bypass, sleeve gastrectomy, and lap band are not asked. No family history beyond the paired MTC/MEN-2 line. No food allergies separate from medication allergies. No pregnancy or breastfeeding screen. No blood pressure or resting heart rate reading. No phone OTP verification β the mobile number is captured for medical-team contact without an SMS code step. No government ID upload. The intake is exceptionally strong on metabolic and chronic-condition screening but light on mental-health, lifestyle, and ID-assurance dimensions.
Source: GLP-1.Reviews editorial walkthrough on April 29, 2026. We completed every screen of the 9amHealth intake using a representative GLP-1 candidate persona and stopped before authorizing the $119 monthly membership.
Opens join9am.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.













